1 dead, 5 in serious condition after 'cannabis-laced' clinical trial in France
Three of the 90 people who took part in the trials may suffer irreversible harm, a doctor said at a televised briefing hosted by Marisol Touraine, the French minister for health, on Friday.
The test, thought to involve an analgesic product containing cannabis, taken orally, took place at a research center approved by the Ministry of Health, Ouest France reported.
Touraine said that patients who took the drug repeatedly had an adverse reaction, calling it an accident of "extraordinary gravity." She noted that all volunteers are being contacted.
According to the Ministry of Health, the ill-fated test was performed at a licensed private institution specializing in the conduct of clinical trials designed to evaluate the safety, tolerability, pharmacological profiles of this molecule in healthy volunteers.
The laboratory has reportedly informed the ANSM (French National Agency for Medicines and Health Products) about the interruption of the trial and is now urgently recalling all the volunteers who took part in it.
The public prosecutor has immediately opened an investigation into the incident. Prosecutors in Rennes have been removed from the case in favor of the public health division of the Paris prosecutor, according to Ouest France.